4//SEC Filing
Levy Adam D. 4
Accession 0000905148-26-000225
CIK 0001781174other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:01 PM ET
Size
4.7 KB
Accession
0000905148-26-000225
Insider Transaction Report
Form 4
Levy Adam D.
Chief Financial Officer
Transactions
- Purchase
Common Stock
[F1]2026-01-14$1.70/sh+8,832$14,999→ 20,983 total
Footnotes (1)
- [F1]The price reported in Column 4 above reflects the weighted average purchase price. This transaction was executed in multiple trades at prices ranging from $1.695 to $1.7086, inclusive. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in footnote 1 of this Form 4.
Signature
/s/ Adam D. Levy|2026-01-16
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0002061876
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:01 PM ET
- Size
- 4.7 KB